University of Birmingham researchers are working with British biotech company, Matoke Holdings Ltd, inventors of Reactive Oxygen® technology, that destroys superbugs such as MRSA and Pseudomonas aeruginosa which cause major hospital-based and community infection
The WHO’s first-ever list of antibiotic-resistant “priority pathogens” names 12 families of bacteria that pose the greatest threat to humans. The list is intended to ensure R&D responds to public health needs
The world needs a global plan to tackle antimicrobial resistance. Alongside a $2B fund to jump-start innovation there should be a $1B reward for companies when a new antibiotic is launched, says Jim O’Neill, chair of the review
To fight growing antimicrobial resistance, the use of existing antimicrobial drugs should be restricted, and there should be incentives for new ones should be developed